VI consensus document by the Spanish Liver Transplantation Society

Stevens, 2013, Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline, Ann Intern Med, 158, 825, 10.7326/0003-4819-158-11-201306040-00007 Ripoll, 2007, Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis, Gastroenterology, 133, 481, 10.1053/j.gastro.2007.05.024 Eason, 2008, Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK), Am J Transplant, 8, 2243, 10.1111/j.1600-6143.2008.02416.x Paramesh, 2012, Kidney transplantation alone in ESRD patients with hepatitis C cirrhosis, Transplantation, 94, 250, 10.1097/TP.0b013e318255f890 Davis, 2007, Simultaneous liver-kidney transplantation: Evaluation to decision making, Am J Transplant, 7, 1702, 10.1111/j.1600-6143.2007.01856.x Nadim, 2012, Simultaneous liver-kidney transplantation summit: Current state and future directions, Am J Transplant, 12, 2901, 10.1111/j.1600-6143.2012.04190.x Francoz, 2010, Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: Impact on the model for end-stage liver disease score, Liver Transpl, 16, 1169, 10.1002/lt.22128 Ruebner, 2012, Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction, Am J Transplant, 12, 2958, 10.1111/j.1600-6143.2012.04177.x Nair, 2002, Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation, Hepatology, 10.1053/jhep.2002.33160 Formica, 2016, Simultaneous liver-kidney allocation policy: A proposal to optimize appropriate utilization of scarce resources, Am J Transplant, 16, 758, 10.1111/ajt.13631 Pichler, 2016, Kidney biopsies may help predict renal function following liver transplantation, Transplantation, 10.1097/TP.0000000000001334 Wong, 2015, The evolving concept of acute kidney injury in patients with cirrhosis, Nat Publ Gr, 12, 711 Levitsky, 2014, Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation, Hepatology, 60, 2017, 10.1002/hep.27346 Northup, 2010, Pretransplant predictors of recovery of renal function after liver transplantation, Liver Transplant, 16, 440 Nadim, 2012, Impact of the etiology of acute kidney injury on outcomes following liver transplantation: Acute tubular necrosis versus hepatorenal syndrome, Liver Transplant, 18, 539, 10.1002/lt.23384 Weismüller, 2015, A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation, Transpl Int, 28, 519, 10.1111/tri.12522 O’Riordan, 2010, Risk score predicting decline in renal function postliver transplant: Role in patient selection for combined liver kidney transplantation, Transplantation, 89, 1378, 10.1097/TP.0b013e3181d9e195 Sharma, 2009, Effect of pretransplant serum creatinine on the survival benefit of liver transplantation, Liver Transpl, 15, 1808, 10.1002/lt.21951 Cochat, 2012, Primary hyperoxaluria type 1: Indications for screening and guidance for diagnosis and treatment, Nephrol Dial Transplant, 27, 1729, 10.1093/ndt/gfs078 Hoppe, 2003, A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria, Pediatr Nephrol, 18, 986, 10.1007/s00467-003-1234-x Drenth, 2010, Medical and surgical treatment options for polycystic liver disease, Hepatology, 52, 2223, 10.1002/hep.24036 van Keimpema, 2011, Excellent survival after liver transplantation for isolated polycystic liver disease: An European Liver Transplant Registry study, Transpl Int, 24, 1239, 10.1111/j.1432-2277.2011.01360.x Corradi, 2016, Predictors of rapid disease progression in autosomal dominant polycystic kidney disease, Minerva Med, 108, 43 Fraser, 2010, Acceptable outcome after kidney transplantation using “Expanded criteria donor” grafts, Transplantation, 89, 88, 10.1097/TP.0b013e3181c343a5 Di Laudo, 2016, Combined liver-dual kidney transplant: Role in expanded donors, Liver Transpl Alhamad, 2014, The outcomes of simultaneous liver and kidney transplantation using donation after cardiac death organs, Transplantation, 98, 1190, 10.1097/TP.0000000000000199 Registro español de trasplante hepático. Dosier hepático. 2015 [accessed 30 Oct 2016]. Available from: http://www.ont.es/. Carlos Haya H.R.U. Inmunosupresión y rechazo. Protocolo de trasplante hepático. Málaga: Hospital Regional Universitario Carlos; 2001. p. 140–164. European Liver Transplant Registry (ELTR) [accessed 30 Oct 2016]. Available from: http://www.eltr.org. Jiménez, 2002, Late liver retransplantation versus early liver retransplantation: Indications and results, Transplant Proc, 34, 304, 10.1016/S0041-1345(01)02774-9 Ghobrial, 2002, Pretransplant model to predict posttransplant survival in liver transplant patients, Ann Surg, 236, 315, 10.1097/00000658-200209000-00008 Sanchez-Bueno, 2005, Emergency organ transplantation in Spain: Liver emergency and outcomes, Transplant Proc, 37, 3878, 10.1016/j.transproceed.2005.09.131 Pfitzmann, 2007, Trends and experiences in liver retransplantation over, Liver Transpl, 13, 248, 10.1002/lt.20904 Chen, 2008, A single centre experience of retrasplantation for liver transplant recipients with a failling graft, Transplant Proc, 40, 1485, 10.1016/j.transproceed.2008.01.076 Enestvedt, 2013, Biliary complications adversely affect patient and graft survival after liver retransplantation, Liver Transpl, 19, 965, 10.1002/lt.23696 Gastaca, 2012, Biliary complications after orthotopic liver transplantation: a review of incidence and risk factors, Transplant Proc, 44, 1545, 10.1016/j.transproceed.2012.05.008 Consejería de Salud. Junta de Andalucía. Boletín de la Junta de Andalucía. Sevilla: edit. Junta de Andalucía. Consejería de salud; 2002, 2011. p. 1–14. Reese, 2009, Transplant center volume and outcomes after liver retransplantation, Am J Transplant, 9, 309, 10.1111/j.1600-6143.2008.02488.x Buchholz, 2017, Retransplantation in late hepatic artery thrombosis: Graft access and transplant outcome, Transplant Direct, 5, e186, 10.1097/TXD.0000000000000705 Busuttil, 2005, Analysis of long-term outcomes of 3200 liver transplantations over two decades: A single-center experience, Ann Surg, 241, 905, 10.1097/01.sla.0000164077.77912.98 Kim, 2010, Impact of MELD on waitlist outcome of retransplant candidates, Am J Transplant, 10, 2652, 10.1111/j.1600-6143.2010.03315.x Selck, 2008, Utilization outcomes and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool, Ann Surg, 248, 599, 10.1097/SLA.0b013e31818a080e Wall, 1997, Recurrent disease after liver transplantation: Implications for the future, Liver Transplant Surg, 6, 362 Torres-Quevedo, 2010, Indications and results of liver retransplantation: experience with 1181 patients in the hospital universitario La Fe, Cir Esp, 87, 356, 10.1016/j.ciresp.2009.10.012 Pérez-Saborido, 2009, Short- and long-term overall results of liver retransplantation:“Doce de Octubre” Hospital experience, Transplant Proc, 41, 2441, 10.1016/j.transproceed.2009.06.045 Bernal Bellido C, Álamo Martínez JM, Marín Gómez LM, Suárez Artacho G, Serrano Díaz Canedo J, Barrera Pulido L, et al. ¿Ha variado la supervivencia en el retrasplante hepático? Actualizaciones en trasplantes 2012. Sevilla; 2013. pp. 158–164. Gómez Bravo, 2014 Shaw, 1985, Hepatic retransplantation, Transplant Proc, 17, 264 Martí, 2008, Optimization of liver grafts in liver retransplantation: A European single-center experience, Surgery, 144, 762, 10.1016/j.surg.2008.06.029 2008, Documento de consenso de la Sociedad Española de Trasplante Hepático. Acceso al trasplante hepático, indicaciones controvertidas, priorización de la lista de espera, Cir Esp, 83, 290, 10.1016/S0009-739X(08)70579-7 Crivellin, 2011, Risk factors in liver retransplantation: A single-center experience, Transplant Proc, 43, 1110, 10.1016/j.transproceed.2011.01.141 Burton, 2004, Retransplantation for recurrent hepatitis C in the MELD era: Maximizing utility, Liver Transpl, 10, S59, 10.1002/lt.20259 Azoulay, 2002, Decision for retransplantation of the liver: An experience an cost based analysis, Ann Surg, 236, 713, 10.1097/00000658-200212000-00003 Meneu Diaz, 2002, Early mortality in liver retransplantation: a multivariate analysis of risk factors, Transplant Proc, 34, 301, 10.1016/S0041-1345(01)02772-5 Watt, 2003, Poor survival after liver retransplantation: Is hepatitis C to blame, Liver Transpl, 9, 1019, 10.1053/jlts.2003.50206 Wiesner, 2003, Model for end-stage liver disease (MELD) and allocation of donor liver, Gastroenterology, 124, 91, 10.1053/gast.2003.50016 Desai, 2004, Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function, Transplantation, 77, 99, 10.1097/01.TP.0000101009.91516.FC Edwards, 2004, Does MELD work for relisted candidates?, Liver Transpl, 10, 510, 10.1002/lt.20271 Malinchoc, 2000, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts, Hepatology, 31, 864, 10.1053/he.2000.5852 Charlton, 2001, Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease, Liver Transpl, 7, 608, 10.1053/jlts.2001.25453 Rosen, 2003, Validation and refinement of survival models for liver retrasplantation, Hepatology, 38, 460, 10.1053/jhep.2003.50328 Reed, 2005, Liver retransplantation: A single-center outcome and financial analysis, Transplant Proc, 37, 1161, 10.1016/j.transproceed.2004.11.046 Evans, 1991 Linhares, 2006, Liver retransplantation: a model for determining long-term survival, Transplantation, 81, 1016, 10.1097/01.tp.0000203798.96491.2f Kashyap, 2001, Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up, Transplant Proc, 33, 1486, 10.1016/S0041-1345(00)02563-X Kim, 2010, Impact of MELD on waitlist outcome of retransplant candidates, Am J Transplant, 10, 2652, 10.1111/j.1600-6143.2010.03315.x Merion, 2004, When is a patient too well and when is a patient too sick for a liver transplant?, Liver Transpl, 10, S69, 10.1002/lt.20265 Feng, 2006, Characteristics associated with liver graft failure: the concept of a donor risk index, Am J Transpl, 6, 783, 10.1111/j.1600-6143.2006.01242.x Marino, 1995, Outcome of liver transplantation using donors 60 to 79 years of age, Transplant Proc, 27, 1184 Grazi, 1991, Influence of donor data on the outcome of liver transplantation, Transplant Proc, 23, 2483 Steib, 2007, Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2), J Hepatol, 47, 228, 10.1016/j.jhep.2007.03.019 Fiorini, 2004, Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice, Am J Transplant, 4, 1567, 10.1111/j.1600-6143.2004.00549.x Pratschke, 2013, Temporary intraoperative porto-caval shunt: Useless or beneficial in piggy back liver transplantation?, Transpl Int, 26, 90, 10.1111/tri.12007 Carrión, 2010, Retransplantation in patients with hepatitis C recurrence after liver transplantation, J Hepatol, 53, 962, 10.1016/j.jhep.2010.06.006 Yoo, 2013, Retransplantation of theh liver: Revieu of current literature for decision making and technical considerations, Transplant Proceed, 45, 854, 10.1016/j.transproceed.2013.02.063 Sheiner, 1997, Retransplantation for hepatitis C, Liver Transpl Surg, 3, 130, 10.1002/lt.500030205 Bellido, 2010, Indicatións and survival ather liver retrasplantation, Transplant Proc, 42, 637, 10.1016/j.transproceed.2010.02.017 Andres, 2012, A score predicting survival after liver retransplantation for hepatitis C virus cirrhosis, Transplantation, 93, 717, 10.1097/TP.0b013e318246f8b3 Forman, 2003, To transplant or not to transplant recurrent hepatitis C and liver failure, Clin Liver Disease, 3, 615, 10.1016/S1089-3261(03)00053-9 Neff, 2004, Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection, Liver Transpl, 10, 1497, 10.1002/lt.20301 Song, 2016, Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence, World J Gastroenterol, 22, 4547, 10.3748/wjg.v22.i18.4547 Kwok, 2016, Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients, Liver Transpl, 22, 1536, 10.1002/lt.24614 Forner, 2016, Diagnóstico y tratamiento del carcinoma hepatocelular. Actualización del documento de consenso de la AEEH, SEOM, SERAM, SERVEI y SETH, Med Clin (Barc), 146, 511.e1, 10.1016/j.medcli.2016.01.028 EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. Eur J Cancer. 2012;48:599–641. Bruix, 2011, Management of hepatocellular carcinoma: An update, Hepatology, 53, 1020, 10.1002/hep.24199 Bruix, 1996, Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure, Gastroenterology, 111, 1018, 10.1016/S0016-5085(96)70070-7 Roayaie, 2013, Resection of hepatocellular cancer ≤2cm: Results from two Western centers, Hepatology, 57, 1426, 10.1002/hep.25832 Llop, 2012, Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors, J Hepatol, 56, 103, 10.1016/j.jhep.2011.06.027 Cescon, 2012, Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma, Ann Surg, 256, 706, 10.1097/SLA.0b013e3182724ce8 Llovet, 1999, Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation, Hepatology, 30, 1434, 10.1002/hep.510300629 Cucchetti, 2009, Is portal hypertension a contraindication to hepatic resection?, Ann Surg, 250, 922, 10.1097/SLA.0b013e3181b977a5 Ishizawa, 2008, Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma, Gastroenterology, 134, 1908, 10.1053/j.gastro.2008.02.091 Berzigotti, 2015, Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis, Hepatology, 61, 526, 10.1002/hep.27431 Poon, 2002, Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation, Ann Surg, 235, 373, 10.1097/00000658-200203000-00009 Imamura, 2003, Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy, J Hepatol, 38, 200, 10.1016/S0168-8278(02)00360-4 Fei, 2016, A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: The neuthophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI), BMC Cancer, 16, 137, 10.1186/s12885-016-2189-1 Zheng, 2016, Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy, Surg Oncol, 25, 171, 10.1016/j.suronc.2016.05.026 Nault, 2013, A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection, Gastroenterlogy, 145, 176, 10.1053/j.gastro.2013.03.051 Fuks, 2012, Benefit ofinitial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention-to-treat analysis, Hepatology, 55, 132, 10.1002/hep.24680 Sala, 2004, High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation, Liver Transpl, 10, 1294, 10.1002/lt.20202 Ferrer-Fàbrega, 2016, Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection, Hepatology, 63, 839, 10.1002/hep.28339 Tribillon, 2016, When should we propose liver transplant after resection of hepatocellular carcinoma? A comparison of Salvage and De Principe strategies, J Gastrointest Surg, 20, 66, 10.1007/s11605-015-3018-6 Lee, 2014, Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation, Liver Transpl, 20, 1057, 10.1002/lt.23919 Chan, 2014, Systematic review of efficacy and outcomes of salvage liver transplantation after primay hepatic resection for hepatocellular carcinoma, J Gastroenterol Hepatol, 29, 31, 10.1111/jgh.12399 Hu, 2012, Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection, Plos One, 7, e36587, 10.1371/journal.pone.0036587 Wu, 2012, Salvage liver transplantion for patients with recurrent hepatocellular carcinoma after curative resection, PloS One, 7, e41820, 10.1371/journal.pone.0041820 Del Gaudio, 2008, Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience, Am J Transpl, 8, 1177, 10.1111/j.1600-6143.2008.02229.x Cherqui, 2009, Liver resection for transplantable hepatocellular carcinoma. Long-term survival and role of secondary liver transplantation, Ann Surg, 250, 738, 10.1097/SLA.0b013e3181bd582b Facciuto, 2008, Surgical Treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation and primary liver transplantation, Ann Surg Oncol, 15, 1383, 10.1245/s10434-008-9851-z Cucchetti, 2010, Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma, Am J Transpl, 10, 619, 10.1111/j.1600-6143.2009.02984.x